New malaria drug for babies offers hope to health workers in Uganda
KAMPALA, Uganda (AP) — Alice Nekesa did not know she was infected with malaria-causing parasites until it was too late. She was in the fourth month of pregnancy last year when she started bleeding, a miscarriage later attributed to untreated malaria in her.
The Ugandan farmer said recently that she regretted the loss of what would have been her second child 'because I didn't discover malaria and treat it early.'
Variations of such cases are commonly reported by Ugandan health workers who witness stillbirths or feverish babies that die within days from undiagnosed malaria. The deaths are part of a wider death toll tied to the mosquito-borne disease, the deadliest across Africa, but one easily treated in adults who seek timely medical care.
Until recently, a major gap in malaria treatment was how to care for newborns and infants infected with malaria who weren't strong enough to receive regular medication. That changed last month when Swiss medical regulators approved medicine from the Basel-based pharmaceutical company Novartis for babies weighing between 2 and 5 kilograms (nearly 4½ to 11 pounds).
Swissmedic said the treatment, a sweet-tasting tablet that disperses into a syrup when dropped into water, was approved in coordination with the World Health Organization under a fast-track authorization process to help developing countries access much-needed treatment.
Africa's 1.5 billion people accounted for 95% of an estimated 597,000 malaria deaths worldwide in 2023, according to the WHO. More than three-quarters of those deaths were among children.
In Uganda, an east African country of 45 million people, there were 12.6 million malaria cases and nearly 16,000 deaths in 2023. Many were children younger than 5 and pregnant women, according to WHO.
Nigeria, Congo and Uganda — in that order — are the African countries most burdened by malaria, a parasitic disease transmitted to humans through the bites of infected mosquitoes that thrive and breed in stagnant water.
The drug approved by Swiss authorities, known as Coartem Baby in some countries and Riamet Baby in others, is a combination of two antimalarials. It is a lower dose version of a tablet previously approved for other age groups, including for older children. Before Coartem Baby, antimalarial drugs designed for older children were administered to small infants with careful adjustments to avoid overdose or toxicity.
Ugandan authorities, who have been working to update clinical guidelines for treating malaria, say the new drug will be rolled out as soon as possible. It is not yet available in public hospitals.
The development of Coartem Baby has given hope to many, with local health workers and others saying the medicine will save the lives of many infants.
Ronald Serufusa, the top malaria official for the district of Wakiso, which shares a border with the Ugandan capital of Kampala, said he believes Coartem Baby will be available 'very, very soon' and that one priority is sensitizing the people adhering to treatment.
Some private pharmacies already have access to Coartem Baby, 'flavored with orange or mango' to make it palatable for infants, he said.
During the so-called malaria season, which coincides with rainy periods twice a year, long lines of sick patients grow outside government-run health centers across Uganda. Many are often women with babies strapped to their backs.
Health workers now are trained to understand that 'malaria can be implicated among newborns,' even when other dangerous conditions like sepsis are present, Serufusa said.
'If they don't expand their investigations to also suspect malaria, then it goes unnoticed,' he said, speaking of health workers treating babies.
The Malaria Consortium, a global nonprofit based in London, in a statement described the approval of Coartem Baby as 'a major leap forward for saving the lives of young children in countries affected by malaria.'
In addition to Uganda, the drug will be rolled out in Burkina Faso, Côte d'Ivoire, Kenya, Malawi, Mozambique, Nigeria, and Tanzania, the group said.
Jane Nabakooza, a pediatrician with Uganda's malaria control program, said she expects the government will make Coartem Baby available to patients free of charge, even after losing funding when the U.S. shrank its foreign aid program earlier this year.
Some malaria funding from outside sources, including the Global Fund to Fight AIDS, Malaria and Tuberculosis, remains available for programs such as indoor spraying to kill mosquitoes that spread the malaria-causing parasite.
Because of funding shortages, 'we are focusing on those that are actually prone to severe forms of malaria and malaria deaths, and these are children under 5 years,' she said.
___
The Associated Press receives financial support for global health and development coverage in Africa from the Gates Foundation. The AP is solely responsible for all content. Find AP's standards for working with philanthropies, a list of supporters and funded coverage areas at AP.org.
Solve the daily Crossword
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Associated Press
an hour ago
- Associated Press
RSF fighters ambush a Sudanese village, killing 7 and burning homes
CAIRO (AP) — A notorious paramilitary group ambushed a village in south-central Sudan, looting and burning several houses, a medical group said Wednesday. At least seven people, including two children, were killed, it said. Tuesday's attack by the Rapid Support Forces on the village of al-Ghabshan al-Maramrah, an agricultural community in North Kordofan province, also wounded 13 others, said the Sudan Doctors Network, a group of medical professionals tracking the Sudanese civil war. The group said RSF fighters looted properties, burned several houses as well as the village's sole health care center, and 'stole the medical supplies stored there.' The RSF did not respond to an Associated Press inquiry about the attack. The attack on the Kordofan village came as the RSF attempted to seize control of the crucial, oil-rich region following a series of battlefield setbacks earlier this year in its war with the Sudanese government. The military kicked the RSF out of major cities in the first half 2025, including Khartoum and its sister city of Omdurman. Last month, RSF fighters rampaged through the village of Shaq al-Num and the surrounding area in Kordofan, killing more than 450 civilians, including 35 children and two pregnant women, according to UNICEF, the United Nations children's agency. Sudan plunged into chaos when simmering tensions between the military and the RSF exploded into open fighting in April 2023 in Khartoum and elsewhere. The fighting has turned into a full-fledged civil war that killed tens of thousands of people, displaced over 14 people out of their homes and pushed parts of the country into famine. The devastating conflict has been marked by atrocities including mass killings and rape, which the International Criminal Court is investigating as war crimes and crimes against humanity. The medical charity Doctors Without Borders, or MSF, meanwhile, said Tuesday it suspended its activities in the main hospital in RSF-controlled Central Darfur province in western Sudan following an armed attack on the facility. The attack happened after two people, one of them dead from a gunshot wound, were brought to the MSF-supported hospital Saturday night. Armed relatives stormed into the facility and tensions escalated among those accompanying the casualties, who reportedly sustained their wounds in a looting incident in a nearby camp, it said. 'Suspending our activities and evacuating our teams is a decision no medical organization wants to make, but our staff cannot risk their lives while providing care,' Marwan Taher, MSF's emergency coordinator in Darfur, said. The group said its operations can't be resumed until it receives 'clear security guarantees to protect staff and patients.'
New York Times
2 hours ago
- New York Times
A Sacred Recipe for Virility or a Dangerous Drug?
The men were told it would save their marriage or help create the perfect first date. Instead many of them ended up drooling uncontrollably, suffering from life-threatening erections and facing a higher risk of heart attacks. The manufacturing and consumption of unregulated drugs meant to enhance the male sex drive have been on the rise across Ivory Coast, a West African nation of 31 million. Customers include young men seeking to impress their partners with displays of unmatched virility. To do so, they take stimulants with side effects they know little about. Although the authorities in Ivory Coast have banned the production of such drugs and are seizing them, they continue to flood the streets of West Africa. Popular products are being exported to neighboring countries and the West, and are available on Amazon and Walmart, where they are advertised as '100 percent natural,' though the ingredients are not listed on the bottle. Products like Attoté, a manufactured beverage, and other so-called artisanal sex stimulants made in Ivory Coast contain high levels of sildenafil, the drug commonly known as Viagra, according to public health officials and laboratory tests obtained by The New York Times. The pills are manufactured in India, smuggled into Ivory Coast, crushed, mixed with other ingredients and sold for $1.50 domestically, $15 in France and $20 in the United States. Up to half of the drugs in West Africa are unregulated, according to the United Nations' drug agency. More than 500,000 people are estimated to die every year in sub-Saharan Africa from the consumption of dangerous, unregulated medications. Sexual stimulants like Attoté are among the most frequently reported, according to the World Health Organization. 'It's coming in from everywhere,' Dr. Assane Coulibaly, the head of Ivory Coast's pharmaceutical regulatory authority, said about the sexual stimulants. 'It's a war.' MALI BURKINA FASO Korhogo IVORY COAST ALGERIA GHANA AFRICA SENEGAL MALI Abidjan Gulf of Guinea IVORY COAST 100 mileS GHANA By The New York Times Want all of The Times? Subscribe.
8 hours ago
New malaria drug for babies offers hope to health workers in Uganda
KAMPALA, Uganda -- Alice Nekesa did not know she was infected with malaria-causing parasites until it was too late. She was in the fourth month of pregnancy last year when she started bleeding, a miscarriage later attributed to untreated malaria in her. The Ugandan farmer said recently that she regretted the loss of what would have been her second child 'because I didn't discover malaria and treat it early.' Variations of such cases are commonly reported by Ugandan health workers who witness stillbirths or feverish babies that die within days from undiagnosed malaria. The deaths are part of a wider death toll tied to the mosquito-borne disease, the deadliest across Africa, but one easily treated in adults who seek timely medical care. Until recently, a major gap in malaria treatment was how to care for newborns and infants infected with malaria who weren't strong enough to receive regular medication. That changed last month when Swiss medical regulators approved medicine from the Basel-based pharmaceutical company Novartis for babies weighing between 2 and 5 kilograms (nearly 4½ to 11 pounds). Swissmedic said the treatment, a sweet-tasting tablet that disperses into a syrup when dropped into water, was approved in coordination with the World Health Organization under a fast-track authorization process to help developing countries access much-needed treatment. Africa's 1.5 billion people accounted for 95% of an estimated 597,000 malaria deaths worldwide in 2023, according to the WHO. More than three-quarters of those deaths were among children. In Uganda, an east African country of 45 million people, there were 12.6 million malaria cases and nearly 16,000 deaths in 2023. Many were children younger than 5 and pregnant women, according to WHO. Nigeria, Congo and Uganda — in that order — are the African countries most burdened by malaria, a parasitic disease transmitted to humans through the bites of infected mosquitoes that thrive and breed in stagnant water. The drug approved by Swiss authorities, known as Coartem Baby in some countries and Riamet Baby in others, is a combination of two antimalarials. It is a lower dose version of a tablet previously approved for other age groups, including for older children. Before Coartem Baby, antimalarial drugs designed for older children were administered to small infants with careful adjustments to avoid overdose or toxicity. Ugandan authorities, who have been working to update clinical guidelines for treating malaria, say the new drug will be rolled out as soon as possible. It is not yet available in public hospitals. The development of Coartem Baby has given hope to many, with local health workers and others saying the medicine will save the lives of many infants. Ronald Serufusa, the top malaria official for the district of Wakiso, which shares a border with the Ugandan capital of Kampala, said he believes Coartem Baby will be available 'very, very soon' and that one priority is sensitizing the people adhering to treatment. Some private pharmacies already have access to Coartem Baby, 'flavored with orange or mango' to make it palatable for infants, he said. During the so-called malaria season, which coincides with rainy periods twice a year, long lines of sick patients grow outside government-run health centers across Uganda. Many are often women with babies strapped to their backs. Health workers now are trained to understand that 'malaria can be implicated among newborns,' even when other dangerous conditions like sepsis are present, Serufusa said. 'If they don't expand their investigations to also suspect malaria, then it goes unnoticed,' he said, speaking of health workers treating babies. The Malaria Consortium, a global nonprofit based in London, in a statement described the approval of Coartem Baby as 'a major leap forward for saving the lives of young children in countries affected by malaria.' In addition to Uganda, the drug will be rolled out in Burkina Faso, Côte d'Ivoire, Kenya, Malawi, Mozambique, Nigeria, and Tanzania, the group said. Jane Nabakooza, a pediatrician with Uganda's malaria control program, said she expects the government will make Coartem Baby available to patients free of charge, even after losing funding when the U.S. shrank its foreign aid program earlier this year. Some malaria funding from outside sources, including the Global Fund to Fight AIDS, Malaria and Tuberculosis, remains available for programs such as indoor spraying to kill mosquitoes that spread the malaria-causing parasite. Because of funding shortages, 'we are focusing on those that are actually prone to severe forms of malaria and malaria deaths, and these are children under 5 years,' she said. ___
